Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
Projects that will be considered for Pfizer support are educational initiatives focused on increasing awareness, early diagnosis and treatment of Primary Immunodeficiencies (children and adults) in underserved/minority communities with the goal to reduce health inequities. Programs that drive patient education and engagement in their care will be prioritized.
Grant Application due date: June 7, 2022
Geographic Scope: United States
• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.
Individual projects requesting up to $200,000 will be considered. The estimated total available budget related to this RFP is $400,000.